AMMJ (AMMJ) Stock Price & Analysis
AMMJ (AMMJ) rose 0.00% to USD 0 as of July 25, 2026 at 05:14 UTC, according to Nexqual real-time market data.
AMMJ last closed at USD 0; the session ranged USD 0–0 on volume of 8,720 shares. Market capitalization is $74,320, with a 52-week range of USD 0–0.01 (PNK). Source: Nexqual, July 25, 2026 at 05:14 UTC.
Key Statistics (as of July 25, 2026 at 05:14 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.01 |
| Volume | 8,720 shares |
| Market Cap | $74,320 |
| Exchange | PNK |
Technical Analysis (AMMJ)
Nexqual's technical model rates AMMJ "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of July 25, 2026 at 05:14 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 40.94 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
Analyst Ratings (AMMJ)
Wall Street analysts rate AMMJ "None", per Nexqual as of July 25, 2026 at 05:14 UTC.
| Consensus Rating | None |
|---|
Earnings (AMMJ)
Source: Nexqual, July 25, 2026 at 05:14 UTC.
Financials & Fundamentals (AMMJ)
| Total Revenue | $1.60M |
|---|---|
| Revenue Growth (YoY) | -49.40% |
| Gross Margin | +12.61% |
| Operating Margin | -128.91% |
| Profit Margin | -248.52% |
| ROE | -927.34% |
| Current Ratio | 0.19 |
| Total Cash | $2,747 |
| Total Debt | $960,024 |
| Free Cash Flow | $1.19M |
Source: Nexqual, July 25, 2026 at 05:14 UTC.
Financial Health Score (AMMJ)
Nexqual rates AMMJ's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 05:14 UTC.
| Growth | Critical — Revenue -49% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $3K cash, no debt |
| Cash Flow | Strong — FCF $1M, 75% margin |
| Efficiency | Critical — ROE -927%, ROA -50.0% |
Ownership (AMMJ)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 185.80M |
| Float | 109.54M |
Source: Nexqual, July 25, 2026 at 05:14 UTC.
Leadership (AMMJ)
AMMJ is led by James Woodend, CEO & Chairman, per Nexqual as of July 25, 2026 at 05:14 UTC.
| CEO & Chairman | James Woodend |
|---|---|
| Vice President of Sales | Jon Workman (age 61) |
| Chairman of the Advisory Board & Interim Presiden | Joseph Cleghorn |
| Interim CFO, Secretary & Director | Shanna Nance (age 50) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DOGP | Dogecoin Cash Inc. | USD 0.01 | ▼ 7.23% |
| CANN | TREES Corporation | USD 0.03 | ▲ 8.05% |
| GRNH | GREENGRO TECHNOLOGIES INC | USD 0 | ▲ 0% |
| CNBX | CNBX Pharmaceuticals Inc. | USD 0 | ▲ 0% |
| ACAN | Americann Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:14 UTC. This page is informational and not investment advice.